Dehydroepiandrosterone (DHEA) Treatment and Premature Ovarian Failure (POF)

Stopped early · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Premature Ovarian Failure

In brief

The experimental focus of this project is on the interaction of DHEA treatment on pregnancy in women with open tubes, fertile male partners and evidence of premature ovarian failure.

Key facts

Study ID

NCT00948857

Run by

David H. Barad

People needed

5

Starts

2009-06-01

Expected to finish

2011-10-01

Last updated by the study team

2012-09-10

Who can join

Age: 21 and older, up to 39. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• >= 1 year of infertility
• >21 and <40 years old
• Normal HSG
• Normal Semen analysis (Count >= 20 million/ motility > 50%/ Kruger morph > 14%.
• Absent menses
• Willingness to sign informed consent for study randomization
• Willingness to participate in 3 months of treatment.

You may not qualify if…

• Abnormal semen analysis
• Abnormal HSG
• Medical condition that would contraindicate pregnancy, ovulation induction or general anesthesia
• Family history of significant genetic disease, or factor V leiden thrombophilia
• Inability to present for monitoring visits
• Inability to follow medication instruction
• Desire to undergo other fertility treatments before completing three months of this trial

Where it is running

• Center for Human Reproduction — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.